Schwazze Cannabis Co Transitions To OTC Expert Market Due To Delayed Filing
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX:SHWZ) (Cboe CA: SHWZ) announced Monday that its common stock will soon transition to the OTC Expert Market, under the ticker symbol “SHWZ.” The Denver-based company said this is due to its delayed filing of its Form 10-Q for the period ended March 31, 2024, with the Securities and Exchange Commission (SEC). The delay was a result of an SEC order regarding the company’s previous auditor, BF Borgers CPA PC, who was dismissed as Schwazze’s auditor prior to the SEC’s order.
In April, Schwazze dismissed BF Borgers as its independent registered public accountant and engaged Baker Tilly US, LLP as its new independent accountant. Subsequent to the transition, on May 3, 2024, the SEC issued an order to BF Borgers and its owner citing the deliberate and systemic failures to comply with public company accounting oversight board(“PCAOB”) standards in its audits and reviews, which were incorporated in more than 1,500 SEC filings from January 2021 through June 2023 and affected …